FSNUF:OTC-Fresenius SE & Co. KGaA (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 37.08

Change

0.00 (0.00)%

Market Cap

USD 20.89B

Volume

N/A

Analyst Target

USD 14.12
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
BDUUY Bangkok Dusit Medical Services..

N/A

USD 13.86B
FMCQF Fresenius Medical Care AG & Co..

N/A

USD 12.25B
RMYHY Ramsay Health Care Ltd ADR

-0.36 (-5.40%)

USD 6.16B
HYHHF Hygeia Healthcare Holdings Co ..

N/A

USD 3.14B
RYHTY Ryman Healthcare Ltd ADR

-0.43 (-2.99%)

USD 2.06B
AEVIF Aevis Victoria SA

N/A

USD 1.69B
DNTCF dentalcorp Holdings Ltd.

N/A

USD 1.16B
RHKJF RHÖN-KLINIKUM Aktiengesellsch..

N/A

USD 0.82B
PFSMF Perfect Medical Health Managem..

N/A

USD 0.70B
EXETF Extendicare Inc

+0.13 (+1.90%)

USD 0.56B

ETFs Containing FSNUF

CEUR:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

-245.00 (-0.50%)

N/A
CEUG:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-1.70 (-0.50%)

USD 1.70B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.90% 69% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.90% 70% C- 72% C
Trailing 12 Months  
Capital Gain 15.88% 71% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.88% 71% C- 67% D+
Trailing 5 Years  
Capital Gain -23.58% 73% C 51% F
Dividend Return 8.44% 55% F 29% F
Total Return -15.14% 73% C 52% F
Average Annual (5 Year Horizon)  
Capital Gain -8.00% 46% F 25% F
Dividend Return -5.42% 49% F 26% F
Total Return 2.58% 57% F 47% F
Risk Return Profile  
Volatility (Standard Deviation) 22.68% 86% B+ 83% B
Risk Adjusted Return -23.90% 40% F 23% F
Market Capitalization 20.89B 100% F 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector